Ethosuximide
Back to searchMolecule Structure
Scientific Name
Ethosuximide
Description of the Drug
Ethosuximide is an anticonvulsant used to treat petit mal seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00593
http://www.drugbank.ca/drugs/DB00593
Brand Name(s)
Emeside, Ethosuximide, Suxinutin, Zarontin
Company Owner(s)
Parke Davis Div Warner Lambert Co, Strides Pharma Global Pte Ltd, Pharmaceutical Associates Inc, Mikart Llc, Teva Pharmaceuticals Usa, Puracap Pharmaceutical Llc, Bionpharma Inc, Heritage Pharmaceuticals Inc, Parke-Davis Division Of Pfizer Inc, Akorn Operating Co Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Voltage-gated T-type calcium channel | PROTEIN FAMILY | BLOCKER | CHEMBL2362995 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL20541518 | SCHEMBL34212 |
PharmGKB | PA449533 | |
Human Metabolome Database | HMDB0014731 | |
DrugBank | DB00593 | |
PubChem: Thomson Pharma | 15219092 | |
PubChem | 3291 | |
Mcule | MCULE-4034034545 | |
LINCS | LSM-5195 | |
Nikkaji | J1.477J | |
BindingDB | 50240424 | |
EPA CompTox Dashboard | DTXSID7023019 | |
DrugCentral | 1087 | |
Brenda | 97926 | |
ChemicalBook | CB1420630 | |
Guide to Pharmacology | 7182 | |
rxnorm | ZARONTIN | ETHOSUXIMIDE |
PubChem: Drugs of the Future | 57304373 | |
KEGG Ligand | C07505 | |
ChEBI | 4887 |